Management of Mucositis with the Use of Leucovorin As Adjunct to Pralatrexate in Treatment of Peripheral T-Cell Lymphomas (PTCL) - Results from a Prospective Multicenter Phase 2 Clinical Trial

被引：3
|
作者：
Shustov, Andrei R. [1 ,2 ]
Shinohara, Michi M. [3 ]
Dakhil, Shaker R. [4 ]
Bhat, Gajanan [5 ]
Zain, Jasmine M. [6 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Univ Washington, Div Hematol, Seattle, WA 98195 USA
[3] Univ Washington, Dept Dermatol, Seattle, WA 98195 USA
[4] Canc Ctr Kansas, Wichita, KS USA
[5] Spectrum Pharmaceut Inc, Irvine, CA USA
[6] City Hope Natl Med Ctr, Dept Hematol Hematopoiet Cell Transplantat, Duarte, CA USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-119684
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2910
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A new prognostic model for peripheral T/NK-cell lymphomas (PTCLS) from prospective multicenter clinical trials
    Watanabe, T.
    Kinoshita, T.
    Itoh, K.
    Yoshimura, K.
    Kaba, H.
    Ogura, M.
    Kagami, Y.
    Yamaguchi, M.
    Kurosawa, M.
    Tsukasaki, K.
    Kasai, M.
    Tobinai, K.
    Mukai, K.
    Nakamura, S.
    Ohshima, K.
    Hotta, T.
    Shimoyama, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 113 - 113
  • [32] A phase II trial of brentuximab vedotin (BV) and lenalidomide (Len) in relapsed and refractory (r/r) cutaneous (CTCL) and peripheral (PTCL) T-cell lymphomas
    Maakaron, J.
    Huang, Y.
    Brammer, J.
    Chung, C.
    William, B.
    EUROPEAN JOURNAL OF CANCER, 2019, 119 : S28 - S28
  • [33] Is there a role for autologous stem-cell transplantation (ASCT) in peripheral T-Cell lymphoma (PTCL)? Final results of a prospective phase II study from the GELCAB.
    Mercadal, Santiago
    Lopez-Guillermo, Armando
    Briones, Javier
    Xicoy, Blanca
    Pedro, Carme
    Escoda, Lourdes
    Estany, Cristina
    Camos, Mireia
    Ribera, Josep-Maria
    Martino, Rodrigo
    Colomo, Llms
    Montserrat, Emili
    BLOOD, 2006, 108 (11) : 874A - 875A
  • [34] Novel Drugs and Clinical Trial-Based Treatments Prolong Survival of Peripheral T-Cell Lymphomas (PTCL) Patients: Single Institution Retrospective Analysis
    Ma, Helen
    Marchi, Enrica
    Cheng, Bin
    Bhagat, Govind
    O'Connor, Owen A.
    BLOOD, 2019, 134
  • [35] The Role of Upfront Hematopoietic Stem Cell Transplantation (HSCT) in Peripheral T-Cell Lymphoma (PTCL) Patients in Complete Remission (CR) with a Special Focus on Nodal PTCL: Report from the Comprehensive Oncology Measures for Peripheral T-Cell Lymphoma Treatment (COMPLETE), a Prospective Multicenter Cohort Study
    Park, Steven I.
    Horwitz, Steven M.
    Foss, Francine M.
    Pinter-Brown, Lauren C.
    Carson, Kenneth R.
    Rosen, Steven T.
    Pro, Barbara
    Hsi, Eric D.
    Federico, Massimo
    Gisselbrecht, Christian
    Schwartz, Marc
    Bellm, Lisa A.
    Acosta, Mark
    Advani, Ranjana H.
    Feldman, Tatyana A.
    Lechowicz, Mary Jo
    Smith, Sonali M.
    Lansigan, Frederick
    Tulpule, Anil
    Craig, Michael
    Greer, John P.
    Kahl, Brad S.
    Leach, Joseph W.
    Morganstein, Neil
    Casulo, Carla
    Shustov, Andrei R.
    BLOOD, 2017, 130
  • [36] Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecified
    Aviles, Agustin
    Castaneda, Claudia
    Neri, Natividad
    Cleto, Sergio
    Talavera, Alejandra
    Gonzalez, Martha
    Huerta-Guzman, Judith
    Nambo, M. Jesus
    MEDICAL ONCOLOGY, 2008, 25 (03) : 360 - 364
  • [37] Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecified
    Agustin Avilés
    Claudia Castañeda
    Natividad Neri
    Sergio Cleto
    Alejandra Talavera
    Martha González
    Judith Huerta-Guzmán
    M. Jesús Nambo
    Medical Oncology, 2008, 25 : 360 - 364
  • [38] Final Results From a Pivotal, Multicenter, International, Open Label, Phase 2 Study of Romidepsin In Progressive or Relapsed Peripheral T-Cell Lymphoma (PTCL) Following Prior Systemic Therapy
    Coiffier, Bertrand
    Pro, Barbara
    Prince, H. Miles
    Foss, Francine M.
    Sokol, Lubomir
    Greenwood, Matthew
    Caballero, Dolores
    Borchmann, Peter
    Morschhauser, Franck
    Wilhelm, Martin
    Pinter-Brown, Lauren
    Padmanabhan, Swaminathan
    Shustov, Andrei
    Nichols, Jean
    Carroll, Susan
    Balser, John
    Horwitz, Steven M.
    BLOOD, 2010, 116 (21) : 56 - 57
  • [39] Intensified Chemo-Immunotherapy Including up-Front Autologous or Allogeneic Stem Cell Transplantation (SCT) for Young Patients with Newly Diagnosed Peripheral T-Cell Lymphomas: Final Results of a Phase II Multicenter Prospective Clinical Trial
    Corradini, Paolo
    Vitolo, Umberto
    Rambaldi, Alessandro
    Miceli, Rosalba
    Patriarca, Francesca
    Gallamini, Andrea
    Olivieri, Attilio
    Benedetti, Fabio
    Todeschini, Giuseppe
    Rossi, Giuseppe
    Parvis, Guido
    Salvi, Flavia
    Bruno, Benedetto
    Baldini, Luca
    Patti, Caterina
    Milone, Giuseppe
    Ferreri, Andres J. M.
    Tarella, Corrado
    Pileri, Stefano A.
    Dodero, Anna
    BLOOD, 2012, 120 (21)
  • [40] Pralatrexate (PDX) produces durable complete remissions in patients with chemotherapy resistant precursor and peripheral T-Cell lymphomas: Results of the MSKCC phase I/II experience.
    O'Connor, Owen A.
    Hamlin, P. A.
    Gerecitano, J.
    Portlock, C. S.
    Noy, A.
    Moskowitz, C.
    Straus, D. J.
    Sarasohn, D.
    Dumetrescu, O.
    Pappanicolou, J.
    Neylon, E.
    Zelenetz, A. D.
    Saunders, M. E.
    Mould, D. R.
    Fleischer, M.
    Sirotnak, F.
    Horwitz, S. M.
    BLOOD, 2006, 108 (11) : 122A - 123A
12345